SCHEDULE: Juniper Investment Discloses 11% Stake in Orthofix Medical

Juniper Investment Company and affiliated entities have disclosed beneficial ownership of approximately 11% of Orthofix Medical Inc.'s outstanding common stock.

Summary

• Juniper Investment Company, along with its associated funds and individuals (Juniper Targeted Opportunity Fund, L.P., Juniper HF Investors II, LLC, Juniper Targeted Opportunities, L.P., Juniper Targeted Opportunity Investors, LLC, Juniper Multi-Strategy Fund, L.P., Juniper HF Investors, LLC, Alexis P. Michas, and John A. Bartholdson), collectively beneficially owns 4,442,543 shares of Orthofix Medical Inc. common stock.
• This represents approximately 11% of the company's outstanding shares as of the Record Date of May 1, 2026.
• The filing is an amendment to a Schedule 13D, indicating a significant ownership stake.
• Recent purchases between February 13, 2026, and May 22, 2026, by Juniper Targeted Opportunity Fund, L.P. amounted to 657,926 shares for approximately $7,413,751.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it indicates significant investor confidence and potential for strategic engagement, but does not provide operational or financial performance updates.

Positives

• Juniper Investment Group has established a significant beneficial ownership stake of 11% in Orthofix Medical Inc., indicating strong conviction in the company's value.
• The group has actively increased its stake through open market purchases, demonstrating a commitment to acquiring shares.
• The filing is an amendment to a Schedule 13D, which is a standard disclosure for significant beneficial ownership changes.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from Orthofix Medical Inc. management. The future actions of Juniper Investment Group regarding their stake are not specified.

Industry Context

StockSavvy.ai notes that significant stake disclosures via Schedule 13D filings often precede activist campaigns or strategic discussions between large shareholders and company management. This filing by Juniper Investment Group, a known investment firm, suggests a potential for increased engagement with Orthofix Medical Inc.'s strategic direction.

Stakeholder Impact

• Shareholders: May see increased volatility or strategic shifts in the company's direction due to the significant stake held by Juniper Investment Group.
• Management: May face increased scrutiny or engagement from Juniper Investment Group regarding company strategy and performance.
• Creditors: No immediate impact indicated, but long-term strategic changes could affect financial stability.

Next Steps

• Monitor future filings from Juniper Investment Group for any changes in ownership or stated intentions.
• Observe Orthofix Medical Inc.'s response and any potential strategic discussions with Juniper Investment Group.

Key Dates

Recommendation

This filing indicates a significant stake by an investment group, which could lead to future strategic actions. However, without specific operational or financial performance data from Orthofix Medical Inc. in this filing, a 'hold' recommendation is prudent, suggesting investors monitor the situation for further developments.

Keywords

Orthofix Medical Inc., Schedule 13D, Juniper Investment Company, Beneficial Ownership, SEC Filing, Common Stock, Investment Fund, Activist Investor